1 duplicate copy in the archive
Scientific overview of CBD pharmacology and clinical trials
Title Matchkaggle-ho-024826
Case Filed-16682House OversightScientific overview of CBD pharmacology and clinical trials
November 11, 20251p3 persons
Case File
d-16682House OversightScientific overview of CBD pharmacology and clinical trials
Other
The passage provides general medical information about CBD and mentions pharmaceutical companies, but contains no specific allegations, financial flows, or connections to powerful officials. It offers Describes the endocannabinoid system and CBD's mechanism of action. Lists FDA‑approved CBD drug (Epidiolex) and companies conducting trials. Notes safety profile and potential drug‑interaction risks
Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #024826
Pages
1
Persons
3
Integrity
No Hash Available
Loading document viewer...
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.